| Name |
Administration |
Indication |
| Fabrazyme® (agalsidase beta) |
non-SAI |
Fabry Disease |
| Feiba® VH (anti-inhibitor
coagulant complex) |
non-SAI |
Hemophilia |
| Firmagon® (degarelix) |
non-SAI |
Cancer |
| Flebogamma® (immune globulin intravenous [human]) |
non-SAI |
Immune Deficiency |
| Flolan® (epoprostenol sodium) |
non-SAI |
Pulmonary Arterial Hypertension |
| Follistim®AQ (follitropin beta, recombinant) |
non-SAI |
Infertility |
| Folotyn™ (pralatrexate) |
non-SAI |
Cancer |
| Forteo® (teriparatide [rDNA origin]) |
SAI |
Osteoporosis |
| Fragmin® (dalteparin sodium) |
SAI |
Deep Vein Thrombosis |
| Fuzeon® (enfuvirtide) |
SAI |
HIV |